FAQs: An Oncology Nurse’s Perspectives on the Management of Adverse Events Associated With CDK4/6 Inhibitor Use for Patients With HR+/HER2- Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
CDK4/6 Inhibitors in Breast Cancer: An Oncology Nurse’s Toolkit to Enhance Tolerability and Preserve Benefit

Content Format:

Video

Credit Type:

ANCC

Credits:

1.00
CDK4/6 Inhibitors in Breast Cancer: An Oncology Nurse’s Toolkit to Enhance Tolerability and Preserve Benefit

Content Format:

Slideset

Credit Type:

--

Credits:

--